Pediatric Asthma

For a multi-center, randomized, double-blind, parallel group clinical trial to compare the efficacy and safety of the dry powder formulation of Drug X to pediatric patients with asthma, Quintiles randomized 450 patients in six months. Using the FaxCollect system and employing SSCs trained in CRF completion enabled Quintiles to lock the database within four weeks of the last patient’s completion of treatment. As a result, Quintiles delivered
the final statistical report to the customer within six weeks of database authorization.  Learn more by reading the case study.